Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Revenue

Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at IDEXX Laboratories (NASDAQ: IDXX) is $1.29 billion. IDEXX had $223.99 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Meridian Bioscience (NASDAQ: VIVO) is $178.82 million. Meridian Bioscience's operating margin for the same period is 29.72%.

The trailing-twelve-month revenue at Abaxis (NASDAQ: ABAX) is $178.79 million. Abaxis' PEG ratio is 3.61.

The trailing-twelve-month revenue at Quidel (NASDAQ: QDEL) is $155.74 million. Quidel's ROE for the same period is 2.59%.